Medisafe 1 Technologies, a developer of patented technologies that physically prevent unauthorised administration of prescription medications, has conducted an official demonstration of its barcoded syringe locking device at Israel's National Ministry of Health.

Medisafe said attendees from the ministry expressed their optimism for the implementation of the device at the nation’s hospitals, and invited the company for a follow-up meeting with ministry professionals serving in operational capacities.

In addition, attending ministry officials discussed the possibility of adding the syringe safety technology to Israel’s nationwide Pharmaceuticals Program, which would grant federal subsidies for the implementation of the technology.

Medisafe 1 Technologies CEO Jacob Elhadad said their demonstration impressed upon the ministry the importance of electronically confirming the administration of a particular medicine or dosage to a patient, and the life-saving benefits of physically preventing the administration of an incorrect medicine or dosage.

"We would like to thank the attending ministry officials including the Deputy Minister for their consideration and enthusiasm, and we look forward to our follow-up meeting with the professionals responsible for the nationwide implementation of medical technologies," Elhadad said.